×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

. (AGLE)

- - (-)

Market Cap: -

As of 12/31/69 07:00 PM EST. Market closed.

(AGLE)

. (AGLE)

-
- (-)

Market Cap: -

As of 12/31/69 07:00 PM EST. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Turtle CameronChief Executive OfficerFeb 15, 2024 Option Exercise$9.824003,928746,907Feb 20, 2024, 09:21 PM
Souza MarcioDirectorAug 25, 2022 Buy$0.5690,00050,47290,000Aug 25, 2022, 07:37 PM
Hanley Jr. Michael ConickChief Commercial OfficerJun 08, 2022 Buy$0.7128,20020,02236,200Jun 10, 2022, 06:24 PM
Quinn Anthony G.President & CEOMar 16, 2022 Buy$2.3480,079187,705550,540Mar 18, 2022, 06:46 AM
Quinn Anthony G.President & CEOMar 15, 2022 Buy$1.8642,41778,942473,461Mar 15, 2022, 06:32 PM
Quinn Anthony G.President & CEOMar 14, 2022 Buy$1.9367,472130,221431,044Mar 15, 2022, 06:32 PM
Quinn Anthony G.President & CEOMar 11, 2022 Buy$2.0634,77771,780363,572Mar 15, 2022, 06:32 PM
Alspaugh JonathanChief Financial OfficerMar 11, 2022 Buy$2.0875,000156,000165,372Mar 15, 2022, 06:30 PM
Shanafelt ArmenDirectorDec 13, 2021 Buy$3.6514,68553,600150,000Dec 13, 2021, 08:41 PM
Shanafelt ArmenDirectorDec 10, 2021 Buy$3.6513,51649,333135,315Dec 13, 2021, 08:41 PM
Shanafelt ArmenDirectorDec 09, 2021 Buy$3.67121,799446,759121,799Dec 13, 2021, 08:41 PM
Quinn Anthony G.President & CEODec 10, 2021 Buy$3.7510,52639,473328,795Dec 13, 2021, 08:39 PM
Quinn Anthony G.President & CEODec 09, 2021 Buy$3.7043,108159,500318,269Dec 13, 2021, 08:39 PM
Alspaugh JonathanChief Financial OfficerDec 09, 2021 Buy$3.7250,000186,00090,372Dec 13, 2021, 08:37 PM
Alspaugh JonathanChief Financial OfficerAug 17, 2021 Buy$6.5023,392151,98533,172Aug 18, 2021, 05:21 PM
Alspaugh JonathanChief Financial OfficerAug 16, 2021 Buy$6.379,78062,2759,780Aug 18, 2021, 05:21 PM
Alspaugh JonathanChief Financial OfficerAug 18, 2021 Buy$6.727,20048,40040,372Aug 18, 2021, 05:21 PM
Quinn Anthony G.President & CEOApr 30, 2020 Buy$4.75165,000783,750538,469May 04, 2020, 07:30 AM
Quinn Anthony G.President & CEOOct 04, 2019 Option Exercise$6.2818,265114,689371,908Oct 07, 2019, 04:09 PM
Quinn Anthony G.President & CEOJun 12, 2019 Buy$6.1112,21774,705333,955Jun 14, 2019, 05:22 PM
Quinn Anthony G.President & CEOJun 14, 2019 Buy$6.235,28232,913353,643Jun 14, 2019, 05:22 PM
Quinn Anthony G.President & CEOJun 13, 2019 Buy$6.1714,40688,836348,361Jun 14, 2019, 05:22 PM
Quinn Anthony G.President & CEOMay 22, 2019 Buy$6.863,80926,128321,738May 22, 2019, 04:55 PM
Quinn Anthony G.President & CEOMay 21, 2019 Buy$6.8913,79494,981317,929May 22, 2019, 04:55 PM
Quinn Anthony G.President & CEOMay 20, 2019 Buy$6.558,98958,923304,135May 22, 2019, 04:55 PM
Quinn Anthony G.President & CEOFeb 15, 2019 Buy$7.107195,103277,152May 17, 2019, 05:04 PM
Quinn Anthony G.President & CEOMay 17, 2019 Buy$6.656,21841,335295,146May 17, 2019, 05:04 PM
Quinn Anthony G.President & CEOMay 16, 2019 Buy$6.835,52037,691288,928May 17, 2019, 05:04 PM
Quinn Anthony G.President & CEOMay 15, 2019 Buy$6.766,25642,269283,408May 17, 2019, 05:04 PM
Quinn Anthony G.President & CEOFeb 06, 2019 Option Exercise$6.188,75654,126276,433Feb 08, 2019, 04:15 PM
Quinn Anthony G.President & CEODec 07, 2018 Option Exercise$4.37171,890751,816267,677Dec 10, 2018, 05:40 PM
Quinn Anthony G.President & CEOAug 15, 2018 Buy$9.139949,07595,787Dec 10, 2018, 05:40 PM
Quinn Anthony G.President & CEOFeb 15, 2018 Buy$6.022,00012,04094,793Dec 10, 2018, 05:40 PM
Schuchart AaronChief Business OfficerSep 27, 2018 Sale$9.506,00057,0058,400Sep 28, 2018, 05:11 PM
Schuchart AaronChief Business OfficerAug 17, 2018 Option Exercise$3.508,50029,7508,500Aug 21, 2018, 04:24 PM
GEORGIOU GEORGEDirectorAug 13, 2018 Option Exercise$5.9137,333220,784175,861Aug 15, 2018, 04:40 PM
Quinn Anthony G.Interim CEOJul 12, 2018 Option Exercise$6.7638,866262,76492,793Jul 16, 2018, 09:04 AM
Quinn Anthony G.Interim CEOJul 11, 2018 Option Exercise$5.463,30718,05653,927Jul 13, 2018, 09:05 AM
Novartis Bioventures Ltd10% OwnerMay 11, 2018 Sale$10.0619,550196,6732,175,314May 14, 2018, 04:01 PM
Novartis Bioventures Ltd10% OwnerMay 10, 2018 Sale$10.1322,725230,2042,194,864May 11, 2018, 04:28 PM
Novartis Bioventures Ltd10% OwnerMay 09, 2018 Sale$10.1151,230517,9352,217,589May 11, 2018, 04:28 PM
Novartis Bioventures Ltd10% OwnerMay 08, 2018 Sale$10.0326,557266,3672,268,819May 09, 2018, 04:01 PM
Novartis Bioventures Ltd10% OwnerMay 07, 2018 Sale$10.1115,548157,1902,295,376May 09, 2018, 04:01 PM
Quinn Anthony G.Interim CEOFeb 15, 2018 Option Exercise$5.4615,21183,05250,620Feb 20, 2018, 12:00 AM
Quinn Anthony G.Interim CEODec 08, 2017 Buy$5.076003,03935,409Dec 08, 2017, 07:06 PM
Quinn Anthony G.Interim CEODec 07, 2017 Buy$4.992,80013,96734,809Dec 08, 2017, 07:06 PM
Quinn Anthony G.Interim CEODec 06, 2017 Buy$4.924,88824,07232,009Dec 08, 2017, 07:06 PM
York Charles N IIChief Financial Officer and VPDec 05, 2017 Buy$4.7610,24148,70034,787Dec 05, 2017, 09:07 PM
York Charles N IIChief Financial Officer and VPDec 04, 2017 Buy$4.973,25916,19724,546Dec 05, 2017, 09:07 PM
York Charles N IIChief Financial Officer and VPDec 01, 2017 Buy$4.596,50029,85521,287Dec 05, 2017, 09:07 PM
York Charles N IIChief Financial Officer and VPAug 15, 2017 Buy$2.521,9594,92914,787Dec 05, 2017, 09:07 PM
York Charles N IIChief Financial Officer and VPFeb 15, 2017 Buy$4.282,0008,56812,828Dec 05, 2017, 09:07 PM
York Charles N IIChief Financial Officer and VPAug 15, 2016 Buy$3.992,0007,97410,828Dec 05, 2017, 09:07 PM
Quinn Anthony G.DirectorDec 05, 2017 Buy$4.935,06524,97627,121Dec 05, 2017, 09:04 PM
Quinn Anthony G.DirectorDec 04, 2017 Buy$4.987,95639,62422,056Dec 05, 2017, 09:04 PM
Quinn Anthony G.DirectorDec 01, 2017 Buy$4.534,10018,57814,100Dec 05, 2017, 09:04 PM
ORBIMED ADVISORS LLC10% OwnerFeb 21, 2017 Buy$5.367,00037,5201,469,524Feb 21, 2017, 05:58 PM
ORBIMED ADVISORS LLC10% OwnerFeb 17, 2017 Buy$5.1971,800372,6421,462,524Feb 21, 2017, 05:58 PM
ORBIMED ADVISORS LLC10% OwnerFeb 16, 2017 Buy$5.0430,500153,7201,390,724Feb 21, 2017, 05:58 PM
LILLY ELI & CO10% OwnerApr 12, 2016 Buy$10.00500,0005,000,0002,568,543Apr 14, 2016, 06:41 PM
Quinn AnthonyDirectorApr 12, 2016 Buy$10.0010,000100,00010,000Apr 12, 2016, 05:10 PM
Novartis Bioventures Ltd10% OwnerApr 12, 2016 Buy$10.00300,0003,000,0002,310,924Apr 12, 2016, 05:09 PM
Cox Russell J.DirectorApr 12, 2016 Buy$10.007,00070,0007,000Apr 12, 2016, 05:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Turtle CameronChief Executive Officer02/15/20243,928
Souza MarcioDirector08/25/202250,472
Hanley Jr. Michael ConickChief Commercial Officer06/08/202220,022
Quinn Anthony G.President & CEO03/16/2022187,705
Quinn Anthony G.President & CEO03/15/202278,942
Quinn Anthony G.President & CEO03/14/2022130,221
Quinn Anthony G.President & CEO03/11/202271,780
Alspaugh JonathanChief Financial Officer03/11/2022156,000
Shanafelt ArmenDirector12/13/202153,600
Shanafelt ArmenDirector12/10/202149,333
Shanafelt ArmenDirector12/09/2021446,759
Quinn Anthony G.President & CEO12/10/202139,473
Quinn Anthony G.President & CEO12/09/2021159,500
Alspaugh JonathanChief Financial Officer12/09/2021186,000
Alspaugh JonathanChief Financial Officer08/17/2021151,985
Alspaugh JonathanChief Financial Officer08/16/202162,275
Alspaugh JonathanChief Financial Officer08/18/202148,400
Quinn Anthony G.President & CEO04/30/2020783,750
Quinn Anthony G.President & CEO10/04/2019114,689
Quinn Anthony G.President & CEO06/12/201974,705
Quinn Anthony G.President & CEO06/14/201932,913
Quinn Anthony G.President & CEO06/13/201988,836
Quinn Anthony G.President & CEO05/22/201926,128
Quinn Anthony G.President & CEO05/21/201994,981
Quinn Anthony G.President & CEO05/20/201958,923
Quinn Anthony G.President & CEO02/15/20195,103
Quinn Anthony G.President & CEO05/17/201941,335
Quinn Anthony G.President & CEO05/16/201937,691
Quinn Anthony G.President & CEO05/15/201942,269
Quinn Anthony G.President & CEO02/06/201954,126
Quinn Anthony G.President & CEO12/07/2018751,816
Quinn Anthony G.President & CEO08/15/20189,075
Quinn Anthony G.President & CEO02/15/201812,040
Schuchart AaronChief Business Officer09/27/201857,005
Schuchart AaronChief Business Officer08/17/201829,750
GEORGIOU GEORGEDirector08/13/2018220,784
Quinn Anthony G.Interim CEO07/12/2018262,764
Quinn Anthony G.Interim CEO07/11/201818,056
Novartis Bioventures Ltd10% Owner05/11/2018196,673
Novartis Bioventures Ltd10% Owner05/10/2018230,204
Novartis Bioventures Ltd10% Owner05/09/2018517,935
Novartis Bioventures Ltd10% Owner05/08/2018266,367
Novartis Bioventures Ltd10% Owner05/07/2018157,190
Quinn Anthony G.Interim CEO02/15/201883,052
Quinn Anthony G.Interim CEO12/08/20173,039
Quinn Anthony G.Interim CEO12/07/201713,967
Quinn Anthony G.Interim CEO12/06/201724,072
York Charles N IIChief Financial Officer and VP12/05/201748,700
York Charles N IIChief Financial Officer and VP12/04/201716,197
York Charles N IIChief Financial Officer and VP12/01/201729,855
York Charles N IIChief Financial Officer and VP08/15/20174,929
York Charles N IIChief Financial Officer and VP02/15/20178,568
York Charles N IIChief Financial Officer and VP08/15/20167,974
Quinn Anthony G.Director12/05/201724,976
Quinn Anthony G.Director12/04/201739,624
Quinn Anthony G.Director12/01/201718,578
ORBIMED ADVISORS LLC10% Owner02/21/201737,520
ORBIMED ADVISORS LLC10% Owner02/17/2017372,642
ORBIMED ADVISORS LLC10% Owner02/16/2017153,720
LILLY ELI & CO10% Owner04/12/20165,000,000
Quinn AnthonyDirector04/12/2016100,000
Novartis Bioventures Ltd10% Owner04/12/20163,000,000
Cox Russell J.Director04/12/201670,000
Load More Insider Transactions
FUNDS WITH A POSITION IN
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
DRIEHAUS CAPITAL MANAGEMENT LLC800,8530.13%ExitedGrowth
SUVRETTA CAPITAL MANAGEMENT, LLC162,3950.11%ExitedGrowth At A Reasonable Price
GEODE CAPITAL MANAGEMENT, LLC26,8000.00004%ExitedOther
RENAISSANCE TECHNOLOGIES LLC23,2290.00049%ExitedOther
BLACKROCK INC.19,7680.00001%ExitedOther
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...